Muteins of clotting factor VIII
US10570189B2 · kind B2 · utility
0Cited by
20References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 4, 2015 |
| Grant date | Feb 25, 2020 |
| Priority date | — |
| Expiry date | Mar 21, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides muteins of FVIII to which a biocompatible polymer may be attached to increase the circulatory half-life of the muteins, as well as conjugates of such muteins and biocompatible polymers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.